1,2-dipalmitoylphosphatidylcholine and Invasiveness, Neoplasm

1,2-dipalmitoylphosphatidylcholine has been researched along with Invasiveness, Neoplasm in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boyd, D; Flaitz, CM; Goepfert, H; Hicks, MJ; Mehta, R; Nemechek, AJ; O'Malley, BW; Simon, C	1

Other Studies

1 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and Invasiveness, Neoplasm

Article	Year
PD 098059, an inhibitor of ERK1 activation, attenuates the in vivo invasiveness of head and neck squamous cell carcinoma. British journal of cancer, 1999, Volume: 80, Issue:9 Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Calcium-Calmodulin-Dependent Protein Kinases; Enzyme Inhibitors; Female; Flavonoids; Head and Neck Neoplasms; Humans; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Mice, Nude; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness	1999

Article

Year

PD 098059, an inhibitor of ERK1 activation, attenuates the in vivo invasiveness of head and neck squamous cell carcinoma.

British journal of cancer, 1999, Volume: 80, Issue:9

Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Calcium-Calmodulin-Dependent Protein Kinases; Enzyme Inhibitors; Female; Flavonoids; Head and Neck Neoplasms; Humans; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Mice, Nude; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness

1999